AMERISAFE reported third-quarter 2026 results in which net premiums earned rose 3.0% to $73.3 million, but net income fell 47.9% to $7.2 million and diluted EPS fell to $0.39 from $0.72. The net combined ratio worsened to 96.5% from 90.6%, as the company cited a more competitive workers' compensation market and higher expenses, which cut into shareholder earnings.
Q3 2026 net income was $7.2 million, versus $13.8 million in Q3 2025; diluted EPS was $0.39, versus $0.72
Net combined ratio was 96.5%, versus 90.6% in Q3 2025; underwriting profit fell 62.6% to $2.5 million
Nine-month 2026 net income was $29.9 million, down 18.5%; book value per share was $12.80 at September 30, 2026
Board declared a quarterly cash dividend of $0.41 per share on October 27, 2026, payable December 11, 2026
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Amerisafe, Inc.'s 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$317.25M
+2.7%
$2.47
-14.5%
14.9%
FY2024
$309.04M
+0.7%
$2.89
-10.5%
17.9%
FY2023
$306.85M
+4.1%
$3.23
+12.2%
20.2%
FY2022
$294.74M
-6.7%
$2.88
-15.0%
18.9%
FY2021
$315.93M
-6.9%
$3.39
-24.2%
20.8%
Frequently asked questions
When is Amerisafe's next earnings date?
Amerisafe has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Amerisafe earn last quarter?
For the quarter ended Sep 2026, Amerisafe reported diluted EPS of $0.39 (-45.8% year over year) on revenue of $79.81M (-2.6%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.